Condición Post-COVID-19: Un largo camino hacia la recuperación 2022

Marta Massanella graduated in Biology at the University Pompeu Fabra (Barcelona) and completed her PhD in Biomedicine at IrsiCaixa under the supervision of Dr. Julià Blanco in 2012. During her PhD, she characterized the immunodiscordant response to ART in HIV-treated individuals and she was involved in several ART-intensification studies. Later on, she joined the laboratory of Dr. Douglas Richman at the University of California San Diego as a post-doctoral fellow, where she developed several assays to quantify the size of the HIV reservoir.

In 2015, she joined Dr. Nicolas Chomont´s laboratory to carry on her studies on the HIV reservoir in the CR-CHUM (Montreal, Canada). Her studies focused on the characterization of different CD4 T-cell subsets in the maintenance of the HIV reservoir. She was also involved in several clinical projects to determine the influence of timing of ART initiation on the establishment and persistence of the HIV reservoir in adults and the paediatric population.

In 2020, she pursued her research as principal investigator at IrsiCaixa to understand the principal mechanisms that contribute to the particular and accelerated immunoaging in the HIV-infected ART-treated population.

Long COVID-19 director. Member of the Infectious Diseases Unit. She is responsible for a monographic consultation on congenital immunodeficiencies and her research is part of the lines of the Infectious Diseases Unit. She is an associate professor of Medicine at the UAB and tutor for internships and seminars in Physiopathology and Clinical Semiology and Biological Basis of Pathology for the UAB Medicine Degree at the Can Ruti Campus.